Certified by Founder Lodge
Insamo
United States - San Francisco Bay Area
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pioneering the discovery of membrane-permeable and orally-available cyclic-peptides with antibody-like binding affinity.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 22 ,2024 | Seed | $12,000,000 |
Playground Global
Sahsen Ventures, LLC
Civilization Ventures
Axial
BEVC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
